MoonLake Immunotherapeutics - Neraca (Quarterly)

MoonLake Immunotherapeutics
US ˙ NasdaqCM ˙ KY61559X1045

Talaan ng Balanse (Quarterly)

Neraca MoonLake Immunotherapeutics menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2021
12-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 8 93 41 40 50 502 318 451 458 343 376 180 272 307
Change (%) 1,053.25 -55.55 -4.12 26.89 900.99 -36.59 41.80 1.61 -25.23 9.59 -51.97 50.51 12.93
Assets Current 10 98 89 77 67 506 500 514 554 537 512 474 506 455
Change (%) 920.86 -10.00 -13.58 -13.08 661.40 -1.26 2.83 7.67 -3.02 -4.58 -7.42 6.74 -10.03
Assets 10 98 89 77 67 507 500 527 564 545 518 478 511 460
Change (%) 916.62 -10.00 -13.26 -13.07 658.45 -1.26 5.26 7.14 -3.41 -4.89 -7.77 6.97 -10.01
Liabilities 21 4 6 8 8 8 11 13 12 15 23 25 99 102
Change (%) -81.83 55.43 34.08 -4.85 -2.26 40.81 23.38 -10.10 26.56 52.98 8.06 302.09 3.52
Equity -12 95 83 69 59 499 490 513 552 530 496 453 413 358
Change (%) -912.00 -12.68 -16.72 -14.04 744.34 -1.90 4.87 7.57 -4.05 -6.51 -8.50 -9.00 -13.24
Liabilities And Stock Equity 10 98 89 77 67 507 500 527 564 545 518 478 511 460
Change (%) 916.62 -10.00 -13.26 -13.07 658.45 -1.26 5.26 7.14 -3.41 -4.89 -7.77 6.97 -10.01

Source: Capital IQ

Other Listings
MX:MLTX N
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista